Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 802-122-7 | CAS number: 4494-16-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Genetic toxicity (mutagenicity) in bacteria in vitro
EC 802-122-7
The in vitro genetic toxicity of Octadec-9-enedioic acid was assessed in a bacterial reverse mutation assay (Ames test), performed according to OECD guideline 471 and under GLP conditions (Queffurus, 2015). S. typhimurium strains TA 1535, TA 1537, TA 1538, TA 98, TA 100 and TA 102 were exposed to concentrations in the range 50 - 5000 µg/plate, with and without metabolic activation. The plate incorporation method was applied in experiment 1 and 3, while the preincubation assay was applied in experiment 2. In experiment 2, cytotoxicity was observed in strain TA 100 from 1600 μg/plate and in TA 1537 at 5000 μg/plate; while in experiment 3, cytotoxicity was observed in strain TA 100 and TA 1535 at 5000 μg/plate. No precipitation was observed. The vehicle (DMSO) and positive controls were shown to be valid. During the first step of experiment 1 without metabolic activation, a ratio R higher than the double of the spontaneous rate of reversion was shown for strain TA 98 at 50 μg/plate and a ratio higher to the triple of the spontaneous rate of reversion was observed for strain TA 1535 at 50 μg/plate. As these results were not reproducible in experiment 2, experiment 3 was performed according to the same protocol as experiment 1. The results were not reproducible in experiment 3 either, and therefore are not considered to be valid. The test substance did not induce an increase in reversions in the S. typhimurium strains tested, with or without metabolic activation.
Genetic toxicity (cytogenicity) in mammalian cells in vitro
EC 802-122-7
The potential of Octadec-9-enedioic acid to induce chromosomal aberrations was assessed using human peripheral blood lymphocytes, in an in vitro mammalian cell micronucleus test performed according to OECD 487 and under GLP conditions (Dewaele, 2015). The lymphocytes were exposed to Octadec-9-enedioic acid in DMSO at concentrations up to 250 µg/mL, with and without metabolic activation (S9-mix). A 4-h treatment was performed with and without metabolic activation, using 62.5, 125 and 250 µg/mL concentration levels with a 28-h expression time. A 24-h treatment without metabolic activation was performed at concentrations of 125, 187.5 and 250 µg/mL with a 48-h expression time. Al l treatments were performed in duplicate and 2000 binucleated cells were evaluated per concentration. The vehicle and positive controls were show to be valid. In the genotoxicity assays with 4-h treatment, the highest concentration of 250 μg/mL induced very slight toxicity with percentages of cytostasis of 19.2 and 14.3%, without and with metabolic activation, respectively, corresponding to replication indexes of 80.8 and 85.7%, when compared with the respective solvent controls. In the genotoxicity assay with 24-h treatment, the highest concentration of 250 μg/mL induced a strong but acceptable cytotoxicity with a percentage of cytostasis of 50.5%, corresponding to a replication index of 49.5%, when compared with the solvent control. The test material did not induce a statistically significant increase in the frequency of cells with chromosome aberrations, measured as micronucleus frequency, with or without metabolic activation.
Overall conclusion for genetic toxicity
There are in vitro studies on genetic toxicity in bacterial cells and in mammalian cells. The results of the available studies were consistently negative. Based on the available data, Octadec-9-enedioic acid (EC 802-122-7), is not considered to be mutagenic.
Justification for selection of genetic toxicity endpoint
No study was selected, as all available in vitro genetic toxicity studies were negative.
Short description of key information:
Ames test (OECD 471): negative in S. typhimurium TA 1535, TA 1537, TA 100, TA 98 and TA 102, with and without metabolic activation
Chromosome aberration in mammalian cells (OECD 487): negative in human peripheral blood lymphocytes with and without metabolic activation
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
The available data on genetic toxicity do not meet the classification criteria according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.